Literature DB >> 2433657

Results of vitrectomy for proliferative diabetic retinopathy.

J T Thompson, S de Bustros, R G Michels, T A Rice, B M Glaser.   

Abstract

The authors treated 1007 eyes with vitrectomy for complications of proliferative diabetic retinopathy. Indications for surgery were: vitreous hemorrhage, 353 eyes (35%); traction retinal detachment, 360 eyes (36%); combined traction-rhegmatogenous retinal detachment, 172 eyes (17%); and other progressive fibrovascular proliferation 122 eyes (12%). During the study period, the frequency of vitreous hemorrhage as an indication for surgery decreased from 42 to 25%, and other progressive fibrovascular proliferation increased from 5 to 22%. The frequency of traction and traction/rhegmatogenous retinal detachments did not change. The results of surgery varied according to the indication. Seventy-nine percent of eyes with vitreous hemorrhage obtained final vision of 5/200 or better. Similar results were obtained in 64% of eyes with traction detachment, 56% of eyes with rhegmatogenous detachment, and 81% of eyes with progressive fibrovascular proliferation. The percentage of eyes achieving final vision of 20/100 or better are as follows: vitreous hemorrhage, 48%; traction detachment, 27%; rhegmatogenous detachment, 24%; and progressive fibrovascular proliferation, 46%. The success rate improved in each anatomic category during the last 3 years of the study.

Entities:  

Mesh:

Year:  1986        PMID: 2433657     DOI: 10.1016/s0161-6420(86)33541-3

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  11 in total

Review 1.  The pars plana incision: experimental studies, pathologic observations, and clinical experience.

Authors:  A E Krieger
Journal:  Trans Am Ophthalmol Soc       Date:  1991

2.  Factors influencing the results of vitreous surgery in diabetic retinopathy. I. Iris rubeosis and/or active neovascularization at the fundus.

Authors:  J Oldendoerp; M Spitznas
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1989       Impact factor: 3.117

3.  Visual and anatomical outcomes following vitrectomy for complications of diabetic retinopathy: the DRIVE UK study.

Authors:  B Gupta; S Sivaprasad; R Wong; A Laidlaw; T L Jackson; D McHugh; T H Williamson
Journal:  Eye (Lond)       Date:  2012-01-06       Impact factor: 3.775

4.  Long-term results of vitreous surgery for proliferative diabetic retinopathy.

Authors:  P Sima; T Zoran
Journal:  Doc Ophthalmol       Date:  1994       Impact factor: 2.379

5.  Surgical outcomes of vitrectomy surgery for proliferative diabetic retinopathy in patients with abnormal renal function.

Authors:  P Larrañaga-Fragoso; H Laviers; C McKechnie; H Zambarakji
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-11-22       Impact factor: 3.117

6.  Macular-threatening traction detachment of the retina in diabetic proliferative retinopathy, treated by laser.

Authors:  D Schmidt
Journal:  Int Ophthalmol       Date:  1997       Impact factor: 2.029

7.  Combined Tractional and Rhegmatogenous Retinal Detachment in Proliferative Diabetic Retinopathy in the Anti-VEGF Era.

Authors:  Ya-Jui Hsu; Yi-Ting Hsieh; Po-Ting Yeh; Jehn-Yu Huang; Chung-May Yang
Journal:  J Ophthalmol       Date:  2014-06-25       Impact factor: 1.909

8.  Intravitreal ranibizumab injection at the end of vitrectomy for diabetic vitreous hemorrhage (Observational Study).

Authors:  Xu Liang; Yue Zhang; Jia-Xing Wang; Li-Fei Wang; Wan-Rong Huang; Xin Tang
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

Review 9.  Current and novel multi-imaging modalities to assess retinal oxygenation and blood flow.

Authors:  Michael J Marino; Peter L Gehlbach; Abhishek Rege; Kim Jiramongkolchai
Journal:  Eye (Lond)       Date:  2021-06-11       Impact factor: 4.456

10.  The outcomes and prognostic factors of vitrectomy in chronic diabetic traction macular detachment.

Authors:  Muneera A Abunajma; Hassan Al-Dhibi; Emad B Abboud; Yahya Al Zahrani; Essam Alharthi; Abdullah Alkharashi; Nicola G Ghazi
Journal:  Clin Ophthalmol       Date:  2016-08-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.